Henrik Hellborg

Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer

Barbro Linderholm, Henrik Hellborg, Unn‐Britt Johansson et al. · Annals of Oncology · 2009 · 339 citations

Surgical Oncology, Breast Oncology, Higher Levels +10

2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial

Peter Gillgren, Krzysztof T. Drzewiecki, Marianne Niin et al. · The Lancet · 2011 · 227 citations

Surgical Oncology, Melanoma, Multicentre Trial +5

Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics

Edoardo Colzani, Annelie Liljegren, Anna L.V. Johansson et al. · Journal of Clinical Oncology · 2011 · 203 citations · Full text

Paget’s disease of the nipple in a population based cohort

Kristina Dalberg, Henrik Hellborg, Fredrik Wärnberg · Breast Cancer Research and Treatment · 2007 · 111 citations

Paget ’, Pathology, Medicine +2

Metastatic Potential in Renal Cell Carcinomas ≤7cm: Swedish Kidney Cancer Quality Register Data

Eirikur Guðmundsson, Henrik Hellborg, Sven Lundstam et al. · European Urology · 2011 · 108 citations

Urology, Genitourinary Cancer, Kidney Research +4